IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
Provided By PR Newswire
Last update: May 6, 2025
SOUTH SAN FRANCISCO, Calif., May 6, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the first quarter that ended March 31, 2025.
Read more at prnewswire.com
